1. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom;Hyams;Lancet Reg Health Eur,2023
2. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study;Lauring;BMJ Br Med J,2022
3. Estimates of SARS-CoV-2 Omicron BA.2 subvariant severity in New England;Strasser;JAMA Netw Open,2022
4. Omicron: increased transmissibility and decreased pathogenicity;Bálint;Signal Transduct Target Ther,2022
5. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: challenges and considerations;Talbot;Infect Control Hosp Epidemiol,2023